Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)
Tobias Welte(Medizinische Hochschule Hannover), Antoní Torres(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), Jean‐Louis Vincent(Université Libre de Bruxelles), Kai Zacharowski(Goethe University Frankfurt), Karl Werdan(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Manu Shankar‐Hari(Centre for Inflammation Research), Ignacio Ayestarán(Hospital Universitario Son Espases), Mervyn Singer(Bury College), Miguel Sánchez García(Hospital Clínico San Carlos), Juan Bonastre Mora(Hospital Universitari i Politècnic La Fe), Steven M. Opal(Brown University), Matthias Kochanek(Centrum für Integrierte Onkologie), Antonio Artigas(Instituto de Salud Carlos III), Ute Achtzehn(Klinikum Chemnitz), Ricard Ferrer(Universitat Autònoma de Barcelona), Ignacio Martín‐Loeches(St. James's Hospital), Gonzalo Sirgo Rodríguez(Institut d'Investigació Sanitària Pere Virgili), Patrick Langohr(Biotest (Germany)), Iris Bobenhausen(Biotest (Germany)), Harald Lapp(Zentralklinik Bad Berka), Henrik Reschreiter(Poole Hospital), David Brealey(UCL Biomedical Research Centre), Daniele Wolf(Biotest (Germany)), Matt P. Wise(University Hospital of Wales), Henning Ebelt(University Hospital in Halle), Benjamin Dälken(Biotest (Germany)), Ulrike Wippermann(Biotest (Germany)), Jörg Brederlau(Helios Hospital Berlin-Buch), Andrea Wartenberg‐Demand(Biotest (Germany)), Stefan Kluge(Universität Hamburg), Francisco Álvarez-Lerma(Hammersmith Hospital), Patrick Dubovy(Biotest (Germany)), Reimer Rießen(German Society of Medical Intensive Care and Emergency Medicine), Miguel Ferrer(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Gabriele Wöbker(Helios Universitätsklinikum Wuppertal), Josep-María Sirvent(Hospital Universitari de Girona Doctor Josep Trueta), Axel Kempa(Katharinenhospital), R. Phillip Dellinger(Cooper Medical School of Rowan University), Jörg Schüttrumpf(Biotest (Germany)), Bernd H. Belohradsky(Ludwig-Maximilians-Universität München), Jordi Almirall(Hospital Sant Jaume de Calella), Monika Mayer(Biotest (Germany)), Sebastian Nuding(University Hospital in Halle)
Cited by 136
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure
|Intensive Care Medicine|1996|11.7k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k